Conrado Utanes
Baltimore, MDNPI 1366414898
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,718 and has fallen 64.7% since, to $607 in 2025.
Across 41 payments — averaging $107.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$775
- AbbVie$537
- Teva Pharmaceuticals USA, Inc.$363
- Amarin Pharma, Inc.$237
- Boehringer Ingelheim$224
- Sanofi-aventis U.S. LLC$211
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,424100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 7 | $775 |
| AbbVie | 5 | $537 |
| Teva Pharmaceuticals USA, Inc. | 3 | $363 |
| Amarin Pharma, Inc. | 2 | $237 |
| Boehringer Ingelheim | 1 | $224 |
| Sanofi-aventis U.S. LLC | 2 | $211 |
| EMD Serono, Inc. | 2 | $210 |
| Neurocrine Biosciences, Inc. | 2 | $209 |
| Boston Scientific | 1 | $138 |
| Ironshore Pharmaceuticals Inc. | 1 | $138 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $122 |
| Aimmune Therapeutics, Inc. | 1 | $120 |
| Novartis | 1 | $118 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $118 |
| Novo Nordisk | 1 | $117 |
| Jazz Pharmaceuticals Inc. | 1 | $116 |
| Idorsia Pharmaceuticals US Inc | 1 | $101 |
| Phathom Pharmaceuticals, Inc. | 1 | $96 |
| Hologic Sales And Service, LLC | 1 | $95 |
| Insmed, Inc. | 1 | $93 |
| Sage Therapeutics, LLC | 1 | $77 |
| Sanofi Pasteur Inc. | 1 | $73 |
| Vertex | 1 | $70 |
| Recordati_rare_diseases_inc. | 1 | $55 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascepa$237
- Austedo XR$226
- INGREZZA$209
- AMS 700 CXR RTE KIT$138
- JORNAY PM$138
- ULTOMIRIS$122
- NEFFY$122
- THYMOGLOBULIN$121
- ZENPEP$120
- LEQVIO$118
- LINZESS$118
- NURTEC ODT$118
- Saxenda$117
- SUNOSI$116
- QUVIVIQ$101
- SOLIRIS$101
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.